Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Chappell

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local controlWai-Man Sze, Anne W M Lee, Tsz-Kok Yau, et al.
Cancer|May 21, 2016
Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockersZachary S Morris, Sandeep Saha, William J Magnuson, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2011
Vitamin D status and early age-related macular degeneration in postmenopausal womenAmy E Millen, Rick Voland, Sherie A Sondel, et al.
Brain Communications|December 18, 2023
Harnessing cognitive trajectory clusterings to examine subclinical decline risk factorsLianlian Du, Bruce P Hermann, Erin M Jonaitis, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment timeAnne W M Lee, Dora L W Kwong, Sing Fai Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical studyCraig A Schulz, Minesh P Mehta, Benham Badie, et al.
Brain Communications|March 13, 2023
Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer's PreventionLianlian Du, Rebecca Langhough, Bruce P Hermann, et al.
Cancer|June 30, 2017
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicityAnne W M Lee, Stewart Y Tung, Wai Tong Ng, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 26, 2016
Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention studyLindsay R Clark, Annie M Racine, Rebecca L Koscik, et al.
Cancer|December 23, 2014
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaAnne W M Lee, Roger K C Ngan, Stewart Y Tung, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local controlWai-Man Sze, Anne W M Lee, Tsz-Kok Yau, et al.
Cancer|May 21, 2016
Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockersZachary S Morris, Sandeep Saha, William J Magnuson, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 13, 2011
Vitamin D status and early age-related macular degeneration in postmenopausal womenAmy E Millen, Rick Voland, Sherie A Sondel, et al.
Brain Communications|December 18, 2023
Harnessing cognitive trajectory clusterings to examine subclinical decline risk factorsLianlian Du, Bruce P Hermann, Erin M Jonaitis, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2002
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment timeAnne W M Lee, Dora L W Kwong, Sing Fai Leung, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical studyCraig A Schulz, Minesh P Mehta, Benham Badie, et al.
Brain Communications|March 13, 2023
Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer's PreventionLianlian Du, Rebecca Langhough, Bruce P Hermann, et al.
Cancer|June 30, 2017
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicityAnne W M Lee, Stewart Y Tung, Wai Tong Ng, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 26, 2016
Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention studyLindsay R Clark, Annie M Racine, Rebecca L Koscik, et al.
Cancer|December 23, 2014
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaAnne W M Lee, Roger K C Ngan, Stewart Y Tung, et al.
Pageof 6